Conflicts Disclosure And Acknowledgments In MSRB Rule G-17 Disclosure Letters

Since August 2, 2012, investment banking firms retained to act as underwriters on municipal finance transactions have been required to provide written disclosure to issuers concerning the relationship between issuers and underwriters, possible conflicts of interest and certain other matters under Municipal Securities Rulemaking Board (MSRB) Rule G-17 (Rule G-17) and MSRB Notice 2012-25 (the "Interpretive Notice"). . The Securities Industry and Financial Markets Association (SIFMA) has provided a model for such disclosure letters (the "SIFMA Model").

The following are some thoughts on the form of the SIFMA Model and on sample disclosure letters received to date by certain issuers represented by this firm:

The sections of the disclosure letters concerning the underwriters' role and underwriters' compensation will likely quickly become boilerplate using the SIFMA Model language, which closely parallels the Interpretive Notice. Many underwriters have been including a section in their form bond purchase agreements to address the role of the underwriters in light of Rule G-17. The section of the disclosure letters concerning "additional conflicts disclosures" is more problematic. While the Interpretive Notice and the SIFMA Model appear to contemplate that underwriters either state that they have not identified "any additional potential or actual material conflicts that require disclosure" or provide a listing on the particular conflicts, most underwriters appear to be taking the approach of listing the various products and services they provide which may give rise to conflicts without actually identifying any conflicts. This approach of not specifying any particular conflict beyond those inherent in the services provided raises issues, discussed in the next paragraph, regarding the issuer acknowledgment of the disclosure. The SIFMA Model contains the following paragraph: "It is our understanding that you have the authority to bind the Issuer by contract with us, and that you are not a party to any conflict of interest relating to the subject...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT